Research at Mass General suggests a novel strategy for enhancing the efficacy and safety of cell replacement therapy in the nervous system, potentially for the treatment of Parkinson's disease. Researchers reveal a new approach for treating degenerative diseases. A therapy that restores brain cells impaired by a rare genetic disorder may offer a strategy for treating conditions like autism, epilepsy, and schizophrenia. The FDA and Gene Therapy for Duchenne Muscular Dystrophy. Experimental gene therapy seems to alleviate symptoms tied to rare diseases, including skeletal defects.
Experimental gene therapy seems to alleviate symptoms tied to rare disease https://t.co/f7Dv6KpFkn
An experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, a new study shows. https://t.co/XPe7DJxKZt
The FDA and Gene Therapy for Duchenne Muscular Dystrophy https://t.co/IIM8iIb8Gw https://t.co/ElmR96JF53
A therapy that restores brain cells impaired by a rare genetic disorder may offer a strategy for treating conditions like autism, epilepsy, and schizophrenia. https://t.co/30dKdxgGay
Researchers reveal a new approach for treating degenerative diseases https://t.co/SWszL9Wxfq
Research at Mass General suggests a novel strategy for enhancing the efficacy and safety of cell replacement therapy in the nervous system, potentially for the treatment of Parkinson's disease. Learn more: https://t.co/6dlFhl3PRu #ParkinsonsMonth https://t.co/RnYPwBVT4a